Clinical Trial Update: CAR-NK Therapy for Cardiac Amyloidosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of CAR-NK therapy for light-chain (AL) cardiac amyloidosis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Cardiac Amyloidosis

Drugs mentioned

• CAR-NK Therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Light Chain Cardiac Amyloidosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING